Health

CVS Selling EpiPen's Competitor Product at One Sixth of the Current Price

0 2149

In September of 2016 the medical community, and the United States congress, were appalled when healthcare company Mylan Inc. announced a 500% price increase (now currently at a cost of $608 dollars) for a two-pack of allergy attack saving EpiPens. The free market once again comes to the rescue as CVS has just announced it is selling a generic version of the drug at a sixth of the price.

Continue Reading

Recommended Reading


Certainly one of the chief guarantees of freedom under any government, no matter how popular and respected, is the right of citizens to keep and bear arms.

- Hubert H. Humphrey